OSTX
8:45 AM
Catalyst Calendar
Thu, Aug 13, 2026
1 updatesWed, Jul 8, 2026
1 updatesMon, Jul 6, 2026
1 updatesOSTX
9:00 AM
OS Therapies Third Quarter 2026 Corporate Outlook
ostherapies.com
Thu, Jul 2, 2026
1 updatesOSTX
7:30 AM
OS Therapies Appoints Dr. Craig Eagle to Board of Directors
ostherapies.com
Tue, Jun 30, 2026
1 updatesOSTX
7:40 AM
OS Therapies Provides U.S. Regulatory Update
ostherapies.com
Fri, Jun 26, 2026
1 updatesMon, Jun 8, 2026
1 updatesOSTX
6:00 AM
OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma
Trial Start • Phase 3Trial initiation Wed, Sep 30, 2026ostherapies.com
Tue, Jun 2, 2026
1 updatesOSTX
6:00 AM
OS Therapies Achieves Statistically Significant 2.5-Year Overall Survival in Phase 2b Trial of OST-HER2 in Fully Resected Pulmonary Metastatic Osteosarcoma
Trial Results • Phase 2MIB Agents Factor 2026 Osteosarcoma Conference presentation Thu, Jun 25, 2026ostherapies.com
Fri, May 29, 2026
1 updatesOSTX
7:20 AM
OS Therapies Announces the Publication of Four Articles on OST-HER2 and Osteosarcoma in Drug Discovery World
Presentation / Abstract • Phase 2ASCO presentation Thu, May 28, 2026ostherapies.com